Private Trust Co. NA Sells 2,787 Shares of Healthpeak Properties, Inc. $DOC

Private Trust Co. NA trimmed its position in Healthpeak Properties, Inc. (NYSE:DOC) by 27.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,226 shares of the real estate investment trust’s stock after selling 2,787 shares during the period. Private Trust Co. NA’s holdings in Healthpeak Properties were worth $127,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of DOC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Healthpeak Properties by 584.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock valued at $186,405,000 after purchasing an additional 7,872,150 shares in the last quarter. Nuveen LLC acquired a new position in shares of Healthpeak Properties in the 1st quarter valued at $124,113,000. Invesco Ltd. increased its position in shares of Healthpeak Properties by 20.7% in the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock valued at $467,311,000 after buying an additional 3,967,830 shares in the last quarter. Nordea Investment Management AB raised its stake in Healthpeak Properties by 7,444.0% during the 2nd quarter. Nordea Investment Management AB now owns 3,923,205 shares of the real estate investment trust’s stock worth $67,871,000 after buying an additional 3,871,201 shares during the period. Finally, Goldman Sachs Group Inc. lifted its holdings in Healthpeak Properties by 57.8% during the first quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust’s stock worth $136,785,000 after acquiring an additional 2,477,307 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a report on Monday, September 15th. Wall Street Zen cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Monday, July 7th. Wells Fargo & Company dropped their target price on shares of Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 27th. Cantor Fitzgerald started coverage on shares of Healthpeak Properties in a report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target for the company. Finally, Evercore ISI set a $22.00 price objective on shares of Healthpeak Properties in a research report on Monday, September 15th. Eight analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.33.

Healthpeak Properties Trading Up 0.1%

NYSE DOC opened at $18.60 on Thursday. Healthpeak Properties, Inc. has a 52 week low of $16.63 and a 52 week high of $23.26. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. The stock’s 50 day moving average price is $18.26 and its two-hundred day moving average price is $17.90. The stock has a market capitalization of $12.92 billion, a price-to-earnings ratio of 77.48, a PEG ratio of 3.17 and a beta of 1.09.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The company had revenue of $694.35 million during the quarter, compared to analysts’ expectations of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The business’s quarterly revenue was down .2% on a year-over-year basis. During the same period last year, the business earned $0.45 EPS. As a group, analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be given a $0.1017 dividend. The ex-dividend date of this dividend is Friday, December 19th. This represents a c) dividend on an annualized basis and a yield of 6.6%. Healthpeak Properties’s dividend payout ratio (DPR) is 508.33%.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 1,490 shares of the business’s stock in a transaction on Monday, August 4th. The shares were purchased at an average cost of $16.83 per share, with a total value of $25,076.70. Following the transaction, the chief executive officer directly owned 211,906 shares of the company’s stock, valued at $3,566,377.98. This represents a 0.71% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In the last quarter, insiders have acquired 8,783 shares of company stock valued at $150,129. 0.23% of the stock is currently owned by insiders.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.